Colorectal cancer (CRC) remains the third most common cause of cancer-related deaths in
both men and women worldwide. Despite recent advances in clinical practice and effective …

Simple Summary Chemotherapy, radiotherapy and molecularly targeted therapy could
improve the prognosis of colorectal cancer (CRC) patients. Recently, immunotherapy …

A number of successful systemic therapies are available for the treatment of disseminated
cancers. However, tumor response is often transient, and therapy frequently fails due to …

Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies,
Volume Eight, summarizes the molecular mechanisms of drug resistance in colorectal …

Simple Summary Colorectal cancer (CRC) causes a high number (more than 800,000) of
deaths worldwide each year. Better methods for early diagnosis and the development of …

Chemoresistance has been found in all malignant tumors including colorectal carcinoma
(CRC). Nowadays chemoresistance is understood as a major reason for therapy failure, with …

Colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in
both men and women worldwide. This is in spite of widespread, effective measures of …

Resistance to chemotherapy limits the effectiveness of current cancer therapies, including
those used to treat colorectal cancer, which is the second most common cause of cancer …

Colorectal cancer (CRC) remains one of the most diagnosed and fatal cancers in China and
worldwide, bringing clinical and economic burdens. Despite recent improvements in …

Colorectal cancer (CRC) is one of the most common cancers and one of the leading causes
of cancer related deaths worldwide. CRC is a heterogeneous disease where there can be …